Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
drugs
Dec 18, 2023, 13:05 |
Blog
Svetlana Nikic: Here is my recent short article on the evaluation of alternative end-points beyond overall survival, when assessing novel cancer therapies
Svetlana Nikic, Founder of Precision Oncology Consulting, recently shared on LinkedIn: "Here is my recent…
Dec 18, 2023, 03:52 |
Drugs
FDA approved enfortumab vedotin-ejfv with pembrolizumab for patients with locally advanced or metastatic urothelial cancer
FDA Oncology shared on X: "On December 15, 2023, the Food and Drug Administration (FDA)…
Dec 17, 2023, 17:26 |
Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Dec 17, 2023, 16:40 |
Blog
Vincent Rajkumar: My head is going to explode
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared a thread on X/Twitter: "This is…
Dec 17, 2023, 03:29 |
Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Dec 16, 2023, 16:58 |
Blog
David Fajgenbaum: Once a drug receives FDA approval, its research and development often slows down
David Fajgenbaum, Founding Director of the Center for Cytokine Storm Treatment and Laboratory, shared a…
Dec 15, 2023, 06:01 |
Blog
Othman Al-Sawaf: The primary analysis of the RT1 study just went online at Nature Medicine
Othman Al-Sawaf, haematologist and medical oncologist at the University Hospital Cologne, Cologne, Germany, shared a…
Dec 13, 2023, 16:21 |
Blog
Miloš Miljković: Our analysis of cancer drug "novelty" and cost
Miloš Miljković, Chief Medical Officer at Cartesian Therapeutics, shared a post by JAMA Network Open…
Dec 12, 2023, 20:11 |
Blog
Aaron Goodman: ASH23 - I won't be in attendance but my question would have been
Aaron Goodman shared a post on X/Twitter: “ASH Plenary: 4 active drugs in myeloma makes more…
Dec 12, 2023, 17:51 |
Insight
Paola Ghanem: Our work on the druggable genomic landscape of GBM is finally out
Paola Ghanem, Resident at the Osler Medical Residency at the Johns Hopkins Hospital, shared on…
71
72
73
74
75
All:
833
Posts:
721 - 730
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube